- Home
- FBRT vs RLAY Comparison
FBRT vs RLAY Comparison
Compare FBRT & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBRT
- RLAY
- Stock Information
- Founded
- FBRT 2012
- RLAY 2015
- Country
- FBRT United States
- RLAY United States
- Employees
- FBRT N/A
- RLAY N/A
- Industry
- FBRT Real Estate Investment Trusts
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FBRT Real Estate
- RLAY Health Care
- Exchange
- FBRT Nasdaq
- RLAY Nasdaq
- Market Cap
- FBRT 882.8M
- RLAY 1.0B
- IPO Year
- FBRT 1985
- RLAY 2020
- Fundamental
- Price
- FBRT $9.96
- RLAY $6.36
- Analyst Decision
- FBRT Strong Buy
- RLAY Strong Buy
- Analyst Count
- FBRT 4
- RLAY 9
- Target Price
- FBRT $14.75
- RLAY $16.00
- AVG Volume (30 Days)
- FBRT 743.3K
- RLAY 2.4M
- Earning Date
- FBRT 10-29-2025
- RLAY 11-06-2025
- Dividend Yield
- FBRT 14.20%
- RLAY N/A
- EPS Growth
- FBRT N/A
- RLAY N/A
- EPS
- FBRT 0.80
- RLAY N/A
- Revenue
- FBRT $241,051,000.00
- RLAY $8,355,000.00
- Revenue This Year
- FBRT $24.35
- RLAY $27.30
- Revenue Next Year
- FBRT $7.16
- RLAY $7.43
- P/E Ratio
- FBRT $12.52
- RLAY N/A
- Revenue Growth
- FBRT 32.77
- RLAY N/A
- 52 Week Low
- FBRT $9.78
- RLAY $1.78
- 52 Week High
- FBRT $13.58
- RLAY $7.64
- Technical
- Relative Strength Index (RSI)
- FBRT 34.90
- RLAY 49.42
- Support Level
- FBRT $9.78
- RLAY $6.04
- Resistance Level
- FBRT $10.20
- RLAY $7.42
- Average True Range (ATR)
- FBRT 0.21
- RLAY 0.40
- MACD
- FBRT -0.02
- RLAY -0.15
- Stochastic Oscillator
- FBRT 16.67
- RLAY 22.78
About FBRT Franklin BSP Realty Trust Inc.
Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. Its segments include the real estate debt business; the real estate securities business; the real estate owned business; and the commercial real estate conduit business.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).